Evidence map›Paper›PMID 38179019›Full record

ArticleBJUI compass2024

Co-designing an online treatment decision aid for men with low-risk prostate cancer: Navigate.

Penelope Schofield, Amelia Hyatt, Alan White, Fiona White, Mark Frydenberg, Suzanne Chambers, Robert Gardiner, Declan G Murphy, Lawrence Cavedon, Jeremy Millar and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BJUI compass, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 1 country.

Penelope SchofieldDepartment of Psychology Swinburne University of Technology Melbourne Victoria Australia.
Amelia HyattHealth Services Research Department Peter MacCallum Cancer Centre Melbourne Victoria Australia.
Alan WhiteHealth Services Research Department Peter MacCallum Cancer Centre Melbourne Victoria Australia.
Fiona WhiteHealth Services Research Department Peter MacCallum Cancer Centre Melbourne Victoria Australia.
Mark FrydenbergDepartment of Urology, Cabrini Institute Cabrini Health Melbourne Victoria Australia.
Suzanne ChambersFaculty of Health Sciences Australian Catholic University Brisbane Queensland Australia.
Robert GardinerSchool of Medicine University of Queensland St Lucia Queensland Australia.
Declan G MurphySir Peter MacCallum Department of Oncology University of Melbourne Parkville Victoria Australia.ORCID https://orcid.org/0000-0002-7500-5899
Lawrence CavedonSchool of Computing Technologies RMIT University Melbourne Victoria Australia.
Jeremy MillarRadiation Oncology, Alfred Health Melbourne Victoria Australia.
Natalie RichardsHealth Services Research Department Peter MacCallum Cancer Centre Melbourne Victoria Australia.
Barbara MurphySchool of Psychological Sciences University of Melbourne Parkville Victoria Australia.ORCID https://orcid.org/0000-0002-6867-5819
Ilona JuraskovaCentre for Medical Psychology and Evidence-based Decision-making (CeMPED), School of Psychology University of Sydney Sydney New South Wales Australia.
The University of Melbourne · AUPeter MacCallum Cancer Centre · AUAlfred Health · AUCabrini Hospital · AUEdith Cowan University · AURMIT University · AUThe University of Sydney · AUUniversity of Technology Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To develop an online treatment decision aid (OTDA) to assist patients with low-risk prostate cancer (LRPC) and their partners in making treatment decisions. Patients and methods: Results: The initial workshops identified key content and design features that were incorporated into the draft OTDA, re-workshopped and incorporated into the penultimate OTDA. Expert feedback on usability and content was also incorporated into the final OTDA. The final OTDA was deemed comprehensive, clear and appropriate and met all IPDAS criteria. Conclusion:

Indexed as

active surveillancelow‐risk prostate canceronline decision aidprostate‐specific antigentreatment decision‐making

Identifiers

PMID38179019
PMCPMC10764164
OpenAlexW4386327137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.